SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001558370-23-016266
Filing Date
2023-10-06
Accepted
2023-10-06 06:32:08
Documents
21
Period of Report
2023-11-15

Document Format Files

Seq Description Document Type Size
1 DEF 14A qure-20231115xdef14a.htm   iXBRL DEF 14A 1799161
2 GRAPHIC qure-20231115xdef14a_a004.jpg GRAPHIC 13982
3 GRAPHIC qure-20231115xdef14a_a006.jpg GRAPHIC 4182
4 GRAPHIC qure-20231115xdef14a_a007.jpg GRAPHIC 5093
5 GRAPHIC qure-20231115xdef14a_a014.jpg GRAPHIC 47140
6 GRAPHIC qure-20231115xdef14a_a015.jpg GRAPHIC 49567
7 GRAPHIC qure-20231115xdef14a_bg001.jpg GRAPHIC 188151
8 GRAPHIC qure-20231115xdef14a_bg002.jpg GRAPHIC 141635
  Complete submission text file 0001558370-23-016266.txt   3789452

Data Files

Seq Description Document Type Size
9 EX-101.SCH qure-20231115.xsd EX-101.SCH 5817
10 EX-101.DEF qure-20231115_def.xml EX-101.DEF 6013
11 EX-101.LAB qure-20231115_lab.xml EX-101.LAB 9364
12 EX-101.PRE qure-20231115_pre.xml EX-101.PRE 6695
16 EXTRACTED XBRL INSTANCE DOCUMENT qure-20231115xdef14a_htm.xml XML 197747
Mailing Address PAASHEUVELWEG 25A AMSTERDAM P7 1105 BP
Business Address PAASHEUVELWEG 25A AMSTERDAM P7 1105 BP 1-339-970-7000
uniQure N.V. (Filer) CIK: 0001590560 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36294 | Film No.: 231312565
SIC: 2834 Pharmaceutical Preparations